[4] Beximco Pharma was founded in 1976 and started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of United States.

[7][8][9] Beximco Pharma became the first company to obtain production and marketing authorization for molnupiravir, the first and only specific oral anti-covid drug in Bangladesh along with Eskayef Pharmaceuticals.

[10][11] Beximco Pharma's branded generic version of molnupiravir is being marketed as Emorivir.

[12] Beximco Pharma manufacturing facilities are spread across a 20-acre (81,000 m2) site located in Dhaka, Bangladesh.

The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.